The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Biosimilars & Follow-on-Biologics-Global Market Insights and Sales Trends 2025
Synopsis
The global Biosimilars & Follow-on-Biologics market size is expected to reach US$ 52070 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biosimilars & Follow-on-Biologics in various end use industries. The expanding demands from the Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases and Growth Hormone Deficiencies, are propelling Biosimilars & Follow-on-Biologics market. Human Growth Hormone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythropoietin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimilars & Follow-on-Biologics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimilars & Follow-on-Biologics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimilars & Follow-on-Biologics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimilars & Follow-on-Biologics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimilars & Follow-on-Biologics covered in this report include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc.
The global Biosimilars & Follow-on-Biologics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Global Biosimilars & Follow-on-Biologics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimilars & Follow-on-Biologics market, Segment by Type:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Global Biosimilars & Follow-on-Biologics market, by Application
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimilars & Follow-on-Biologics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Biosimilars & Follow-on-Biologics market size is expected to reach US$ 52070 million by 2029, growing at a CAGR of 15.0% from 2023 to 2029. The market is mainly driven by the significant applications of Biosimilars & Follow-on-Biologics in various end use industries. The expanding demands from the Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases and Growth Hormone Deficiencies, are propelling Biosimilars & Follow-on-Biologics market. Human Growth Hormone, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Erythropoietin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Biosimilars & Follow-on-Biologics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Biosimilars & Follow-on-Biologics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Biosimilars & Follow-on-Biologics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Biosimilars & Follow-on-Biologics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Biosimilars & Follow-on-Biologics covered in this report include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc.
The global Biosimilars & Follow-on-Biologics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Global Biosimilars & Follow-on-Biologics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biosimilars & Follow-on-Biologics market, Segment by Type:
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Global Biosimilars & Follow-on-Biologics market, by Application
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Biosimilars & Follow-on-Biologics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Biosimilars & Follow-on-Biologics
1.1 Biosimilars & Follow-on-Biologics Market Overview
1.1.1 Biosimilars & Follow-on-Biologics Product Scope
1.1.2 Biosimilars & Follow-on-Biologics Market Status and Outlook
1.2 Global Biosimilars & Follow-on-Biologics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Biosimilars & Follow-on-Biologics Market Size by Region (2018-2029)
1.4 Global Biosimilars & Follow-on-Biologics Historic Market Size by Region (2018-2023)
1.5 Global Biosimilars & Follow-on-Biologics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Biosimilars & Follow-on-Biologics Market Size (2018-2029)
1.6.1 North America Biosimilars & Follow-on-Biologics Market Size (2018-2029)
1.6.2 Europe Biosimilars & Follow-on-Biologics Market Size (2018-2029)
1.6.3 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size (2018-2029)
1.6.4 Latin America Biosimilars & Follow-on-Biologics Market Size (2018-2029)
1.6.5 Middle East & Africa Biosimilars & Follow-on-Biologics Market Size (2018-2029)
2 Biosimilars & Follow-on-Biologics Market by Type
2.1 Introduction
2.1.1 Human Growth Hormone
2.1.2 Erythropoietin
2.1.3 Monoclonal Antibodies
2.1.4 Insulin
2.1.5 Interferon
2.1.6 Granulocyte-Colony Stimulating Factor
2.1.7 Peptide
2.1.8 Others
2.2 Global Biosimilars & Follow-on-Biologics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Biosimilars & Follow-on-Biologics Historic Market Size by Type (2018-2023)
2.2.2 Global Biosimilars & Follow-on-Biologics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Biosimilars & Follow-on-Biologics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Biosimilars & Follow-on-Biologics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Biosimilars & Follow-on-Biologics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Biosimilars & Follow-on-Biologics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Biosimilars & Follow-on-Biologics Revenue Breakdown by Type (2018-2029)
3 Biosimilars & Follow-on-Biologics Market Overview by Application
3.1 Introduction
3.1.1 Blood Disorders
3.1.2 Oncology Diseases
3.1.3 Chronic and Autoimmune Diseases
3.1.4 Growth Hormone Deficiencies
3.1.5 Others
3.2 Global Biosimilars & Follow-on-Biologics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Biosimilars & Follow-on-Biologics Historic Market Size by Application (2018-2023)
3.2.2 Global Biosimilars & Follow-on-Biologics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Biosimilars & Follow-on-Biologics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Biosimilars & Follow-on-Biologics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Biosimilars & Follow-on-Biologics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Biosimilars & Follow-on-Biologics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Biosimilars & Follow-on-Biologics Revenue Breakdown by Application (2018-2029)
4 Biosimilars & Follow-on-Biologics Competition Analysis by Players
4.1 Global Biosimilars & Follow-on-Biologics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biosimilars & Follow-on-Biologics as of 2022)
4.3 Date of Key Players Enter into Biosimilars & Follow-on-Biologics Market
4.4 Global Top Players Biosimilars & Follow-on-Biologics Headquarters and Area Served
4.5 Key Players Biosimilars & Follow-on-Biologics Product Solution and Service
4.6 Competitive Status
4.6.1 Biosimilars & Follow-on-Biologics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.1.4 Novartis Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Synthon Pharmaceuticals
5.2.1 Synthon Pharmaceuticals Profile
5.2.2 Synthon Pharmaceuticals Main Business
5.2.3 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.2.4 Synthon Pharmaceuticals Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.2.5 Synthon Pharmaceuticals Recent Developments
5.3 Teva Pharmaceutical Industries
5.3.1 Teva Pharmaceutical Industries Profile
5.3.2 Teva Pharmaceutical Industries Main Business
5.3.3 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.3.4 Teva Pharmaceutical Industries Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.3.5 LG Life Sciences Recent Developments
5.4 LG Life Sciences
5.4.1 LG Life Sciences Profile
5.4.2 LG Life Sciences Main Business
5.4.3 LG Life Sciences Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.4.4 LG Life Sciences Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.4.5 LG Life Sciences Recent Developments
5.5 Celltrion
5.5.1 Celltrion Profile
5.5.2 Celltrion Main Business
5.5.3 Celltrion Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.5.4 Celltrion Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.5.5 Celltrion Recent Developments
5.6 Biocon
5.6.1 Biocon Profile
5.6.2 Biocon Main Business
5.6.3 Biocon Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.6.4 Biocon Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.6.5 Biocon Recent Developments
5.7 Hospira
5.7.1 Hospira Profile
5.7.2 Hospira Main Business
5.7.3 Hospira Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.7.4 Hospira Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.7.5 Hospira Recent Developments
5.8 Merck Group
5.8.1 Merck Group Profile
5.8.2 Merck Group Main Business
5.8.3 Merck Group Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.8.4 Merck Group Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Group Recent Developments
5.9 Biogen idec, Inc.
5.9.1 Biogen idec, Inc. Profile
5.9.2 Biogen idec, Inc. Main Business
5.9.3 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.9.4 Biogen idec, Inc. Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.9.5 Biogen idec, Inc. Recent Developments
5.10 Genentech (Roche Group)
5.10.1 Genentech (Roche Group) Profile
5.10.2 Genentech (Roche Group) Main Business
5.10.3 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Products, Services and Solutions
5.10.4 Genentech (Roche Group) Biosimilars & Follow-on-Biologics Revenue (US$ Million) & (2018-2023)
5.10.5 Genentech (Roche Group) Recent Developments
6 North America
6.1 North America Biosimilars & Follow-on-Biologics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Biosimilars & Follow-on-Biologics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Biosimilars & Follow-on-Biologics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Biosimilars & Follow-on-Biologics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Biosimilars & Follow-on-Biologics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Biosimilars & Follow-on-Biologics Market Dynamics
11.1 Biosimilars & Follow-on-Biologics Industry Trends
11.2 Biosimilars & Follow-on-Biologics Market Drivers
11.3 Biosimilars & Follow-on-Biologics Market Challenges
11.4 Biosimilars & Follow-on-Biologics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
